270 related articles for article (PubMed ID: 31898336)
1. Comprehensive analysis of biological networks and the eukaryotic initiation factor 4A-3 gene as pivotal in hepatocellular carcinoma.
Lin Y; Liang R; Mao Y; Ye J; Mai R; Gao X; Liu Z; Wainwright T; Li Q; Luo M; Ge L; Li Y; Zou D
J Cell Biochem; 2020 Oct; 121(10):4094-4107. PubMed ID: 31898336
[TBL] [Abstract][Full Text] [Related]
2. eIF4A3 Phosphorylation by CDKs Affects NMD during the Cell Cycle.
Ryu I; Won YS; Ha H; Kim E; Park Y; Kim MK; Kwon DH; Choe J; Song HK; Jung H; Kim YK
Cell Rep; 2019 Feb; 26(8):2126-2139.e9. PubMed ID: 30784594
[TBL] [Abstract][Full Text] [Related]
3. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.
Zheng X; Huang M; Xing L; Yang R; Wang X; Jiang R; Zhang L; Chen J
Mol Cancer; 2020 Apr; 19(1):73. PubMed ID: 32264877
[TBL] [Abstract][Full Text] [Related]
4. CDK1-PLK1/SGOL2/ANLN pathway mediating abnormal cell division in cell cycle may be a critical process in hepatocellular carcinoma.
Li L; Huang K; Zhao H; Chen B; Ye Q; Yue J
Cell Cycle; 2020 May; 19(10):1236-1252. PubMed ID: 32275843
[TBL] [Abstract][Full Text] [Related]
5. Circ ubiquitin-like-containing plant homeodomain and RING finger domains protein 1 increases the stability of G9a and ubiquitin-like-containing plant homeodomain and RING finger domains protein 1 messenger RNA through recruiting eukaryotic translation initiation factor 4A3, transcriptionally inhibiting PDZ and homeobox protein domain protein 1, and promotes the metastasis of hepatocellular carcinoma.
Huang X; Zhou LZ; Feng WJ; Liu YQ; Chen M; Tang LY; Gan ZY; Zhang P
J Gastroenterol Hepatol; 2024 Mar; 39(3):596-607. PubMed ID: 38059880
[TBL] [Abstract][Full Text] [Related]
6. Hsa_circ_0005397 promotes hepatocellular carcinoma progression through EIF4A3.
Yuan LX; Luo M; Liu RY; Wang HX; Ju LL; Wang F; Cao YL; Wang ZC; Chen L
BMC Cancer; 2024 Feb; 24(1):239. PubMed ID: 38383334
[TBL] [Abstract][Full Text] [Related]
7. Expression and gene regulation network of
Lin Y; Liang R; Qiu Y; Lv Y; Zhang J; Qin G; Yuan C; Liu Z; Li Y; Zou D; Mao Y
Aging (Albany NY); 2019 Jan; 11(2):423-447. PubMed ID: 30670676
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological systems analysis defines EIF4A3 functions in cell-cycle and RNA stress granule formation.
Mazloomian A; Araki S; Ohori M; El-Naggar AM; Yap D; Bashashati A; Nakao S; Sorensen PH; Nakanishi A; Shah S; Aparicio S
Commun Biol; 2019; 2():165. PubMed ID: 31069274
[TBL] [Abstract][Full Text] [Related]
9. Hsa_circ_0004296 inhibits metastasis of prostate cancer by interacting with EIF4A3 to prevent nuclear export of ETS1 mRNA.
Mao S; Zhang W; Yang F; Guo Y; Wang H; Wu Y; Wang R; Maskey N; Zheng Z; Li C; Ma W; Zhang J; Yan Y; Yao X
J Exp Clin Cancer Res; 2021 Oct; 40(1):336. PubMed ID: 34696782
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA LINC00630 facilitates hepatocellular carcinoma progression through recruiting transcription factor E2F1 to up-regulate cyclin-dependent kinase 2 expression.
Kang J; Huang X; Dong W; Zhu X; Li M; Cui N
Hum Exp Toxicol; 2021 Dec; 40(12_suppl):S257-S268. PubMed ID: 34420405
[TBL] [Abstract][Full Text] [Related]
11. Prognostic potential of PRPF3 in hepatocellular carcinoma.
Liu Y; Yang Y; Luo Y; Wang J; Lu X; Yang Z; Yang J
Aging (Albany NY); 2020 Jan; 12(1):912-930. PubMed ID: 31926109
[TBL] [Abstract][Full Text] [Related]
12. Systematic Analysis of Gene Expression Alteration and Co-Expression Network of Eukaryotic Initiation Factor 4A-3 in Cancer.
Lin Y; Zhang J; Cai J; Liang R; Chen G; Qin G; Han X; Yuan C; Liu Z; Li Y; Zou D; Mao Y
J Cancer; 2018; 9(24):4568-4577. PubMed ID: 30588240
[No Abstract] [Full Text] [Related]
13. An RNAi screen of RNA helicases identifies eIF4A3 as a regulator of embryonic stem cell identity.
Li D; Yang J; Malik V; Huang Y; Huang X; Zhou H; Wang J
Nucleic Acids Res; 2022 Nov; 50(21):12462-12479. PubMed ID: 36416264
[TBL] [Abstract][Full Text] [Related]
14. EIF4A3-induced circTOLLIP promotes the progression of hepatocellular carcinoma via the miR-516a-5p/PBX3/EMT pathway.
Liu Y; Song J; Zhang H; Liao Z; Liu F; Su C; Wang W; Han M; Zhang L; Zhu H; Zhang Z; Liang H; Zhang L; Zhang B; Chen X
J Exp Clin Cancer Res; 2022 May; 41(1):164. PubMed ID: 35509064
[TBL] [Abstract][Full Text] [Related]
15. Spliceosomal profiling identifies EIF4A3 as a novel oncogene in hepatocellular carcinoma acting through the modulation of FGFR4 splicing.
López-Cánovas JL; Hermán-Sánchez N; Moreno-Montilla MT; Del Rio-Moreno M; Alors-Perez E; Sánchez-Frias ME; Amado V; Ciria R; Briceño J; de la Mata M; Castaño JP; Rodriguez-Perálvarez M; Luque RM; Gahete MD
Clin Transl Med; 2022 Nov; 12(11):e1102. PubMed ID: 36419260
[TBL] [Abstract][Full Text] [Related]
16. Key signaling pathways, genes and transcription factors associated with hepatocellular carcinoma.
Wang J; Tian Y; Chen H; Li H; Zheng S
Mol Med Rep; 2018 Jun; 17(6):8153-8160. PubMed ID: 29658607
[TBL] [Abstract][Full Text] [Related]
17. CWC22-dependent pre-mRNA splicing and eIF4A3 binding enables global deposition of exon junction complexes.
Steckelberg AL; Altmueller J; Dieterich C; Gehring NH
Nucleic Acids Res; 2015 May; 43(9):4687-700. PubMed ID: 25870412
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatics analysis of key genes and pathways for hepatocellular carcinoma transformed from cirrhosis.
He B; Yin J; Gong S; Gu J; Xiao J; Shi W; Ding W; He Y
Medicine (Baltimore); 2017 Jun; 96(25):e6938. PubMed ID: 28640074
[TBL] [Abstract][Full Text] [Related]
19. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
20. Prediction and analysis of weighted genes in hepatocellular carcinoma using bioinformatics analysis.
Zhang Q; Sun S; Zhu C; Zheng Y; Cai Q; Liang X; Xie H; Zhou J
Mol Med Rep; 2019 Apr; 19(4):2479-2488. PubMed ID: 30720105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
